Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SECURE: Polypill for Secondary CV Prevention in the Elderly
NCT02596126Phase 3Completed
- Sponsor
- Centro Nacional de Investigaciones Cardiovasculares
- Start
- Jul 2016
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
- Countries
- 7
01
Overview
A Phase 3 trial of aspirin, ramipril, atorvastatin in myocardial infarction (MI), cardiovascular disease (CVD), sponsored by Centro Nacional de Investigaciones Cardiovasculares. Started Jul 2016; status: completed.
02
Drugs
aspirinramiprilatorvastatin
03
Conditions
myocardial infarction (MI)cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02596126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02596126.